CALY-002
N/A
Report date: 2024/11/07 13:49:48
Base Information
Drug NameCALY-002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdd Biotech
China Registration ClassN/A
Develop Information
Active CompaniesNovartis AgCalypso Biotech Bv
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A